European Archives - Page 215 of 1509 - European Medical Journal

Scotland sets £25bn target for life sciences by 2035

Scotland has announced a major new plan to grow its life sciences sector, aiming to boost economic growth and healthcare innovation.

Exercise reduces pain and fatigue in systemic sclerosis - EMJ

Tailored Exercise Programme Reduces Pain and Fatigue in Systemic Sclerosis

New trial shows high-intensity exercise can ease pain and fatigue in systemic sclerosis, improving quality of life and physical function after just 12 weeks.

Multilingualism May Delay Ageing, Major Study Finds - EMJ

Multilingualism May Delay Ageing, Major Study Finds

A study of over 86,000 adults across Europe finds that speaking multiple languages is associated with healthier ageing and lower risk of accelerated ageing.

Comprehensive Myeloid Neoplasm Genomics Dataset Released

Validated dataset with 14,441 clinicopathologic and genomic reports supports myeloid neoplasm diagnosis and research globally.

Flu Rising Unusually Early This Season, Reports UKHSA

The latest UKHSA winter surveillance bulletin shows flu activity rising unusually early, while COVID-19 remains low and RSV begins to increase.

Nicolas Girard, Head of Medical Oncology at Institut Curie, Paris

Onc Now: Episode 30: Where is Lung Cancer Research Heading Next?

Thoracic oncology expert Professor Nicolas Girard, discusses the evolving landscape of lung cancer treatment including current standards of care, practice-changing research, and the impact of precision medicine and immunotherapy on patient outcomes.

Chronic Hepatitis C Linked to Higher Risk of Pancreatic Cancer - EMJ

Chronic Hepatitis C Linked to Higher Risk of Pancreatic Cancer

Chronic hepatitis C infection has been linked to a higher risk of pancreatic cancer.

Targeted Therapy for Interstitial Lung Disease and the Role of Nerandomilast

This article reviews data on the efficacy and safety of nerandomilast in IPF and PPF, including the latest updates presented at ATS 2025…

Combination therapy improves outcomes in persistent paediatric scabies - EMJ

Ivermectin/Permethrin Dual Treatment Significantly Improves Outcomes in Paediatric Persistent Scabies

A study shows adding oral ivermectin to permethrin improves cure rates and speeds symptom relief in children with persistent scabies, with regular follow-up over several months.

EMJ Respiratory 13 [Supplement 2] 2025

Our latest symposium review summarises several Boehringer Ingelheim presentations and posters on the role of nerandomilast, an oral…